PMS2 and neoplasm: The latter are particularly potent against MSI-high solid tumors, which contain numerous gene mutations.1) MMR protein (MLH1, MSH2, MSH6, and PMS2) expression in tumor tissues was examined immunohistochemically to assess for dMMR, defined as the loss of expression of 1 or more proteins.